# Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

> **Open Intelligence Dossier** · First detected: 2026-10-24 23:00 UTC · Category: Business

## Executive Summary
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer" is generating significant coverage in the Business category, with 6 articles from 6 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Bloomberg.com, Reuters, Fierce Pharma and NBC News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Bloomberg.com | Amgen, Astra Drug Duo Boosts Survival for Deadly Lung Cancer | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxOVDE5bWpnTU9PcC1LeFhwR0RGSG14T3JkSTlWM2lvRENZNHltVVpOX1E4cGRwOGVVNklYeEgyRnRhM3VhSGY3cF80Q1VDaTRJM2R0RzhXa1FZY0F6M1NGNzBodWJLLXRNZ2FrLU9TbVV1VlQ1THhzZGlEclF5alhtUUlSS2VKZGtLSkZhUjFpMGhCcG5KZDhrVjB0d3daMUZWV1NXVmN5eV9EVGlJQ0cw?oc=5) |
| Reuters | Amgen drug combined with immunotherapy extends survival in lung cancer trial | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxQNkp5SkpQWTcySnpWVEtXVGN2azJZYnFERjh6WHJBR3NPcEE0TDNGWUVuQ0Q0WF91VnFFVkRYZjF1NFJ3N01XdzVTZzNXQ0F4NlVMMzVZY0JUNldtZW1CS0hSX3d4TUZVZ3lfX2xjeVF6UElWanluMXNOV05ybUdFb2YwbUJ2eGY3NkR0ZUhabWhaMGp5SERfajdZMzlUcGZsX3RULXNZMlI1eTMwbjFxWTlweW5uNHpNTWlVbmVKS2libTlG?oc=5) |
| Fierce Pharma | ESMO: Amgen’s Imdelltra drives massive survival benefit in ‘watershed moment’ for small cell lung cancer | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxNSE9oeUx3X0lfMTdhNDVQaEFwRkxsV0lvNnhfUEQ3c09LWEN4eXJFb18tSFFUNFJDN0hoNVZtc0w5bWw2d2tGQkFROUlSS1VGUVhiakJ1Z3Y2c1RmTTRUV3pOVXZVNER2TGJUTVRHTnUxYURmY0g0UVFQcmEzRHlQLVFWNy12TS1NaGN3eXhmZWEwcS1QdERZc0U0cVZuRzBjb1FUZ1VaTjhldWdYcEpXYm1TOGZTUWhVOXNxbjBWekU?oc=5) |
| NBC News | ‘Practice-changing’ new lung cancer immunotherapy improves survival | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxNNnBualdkd0l2cjluOXlUX0RpQkVGQl9PUmFZcndDSkozcWhWRDE1WnlJcm1PYTg4T3pySlN6WnhCZ0V1MzVyb01aX25saHpuRDVFNU9tWDdFUXZFNWl1cWJXNFNSOUhrNG04SzV3U0RqbjhQdGRyS0I4MERRODJYTkozSU5Dc1p4T2ZvcjFyMlpyUURlZXRvTEh0cDRxMVl4NVQ4M2ZR?oc=5) |
| Amgen | IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER | [Source Link](https://news.google.com/rss/articles/CBMilwJBVV95cUxPSWdPdzgtVHY4b013bEN4MDNYYmJ1cEJfTG51a2FZeUxPZ1BKUFVza2NTcGZfNlB5Sm9ZQ3ljR3JsOEFZTHpfQVc5dzdfSTBJWUxLRkFnYm14TXZ4T2ZRdm0wYmZDckJXUkdVMXFDU1BTWjRZaVUxZlk5cVBGZEtFQWhfdW5RYldxYW1ZMWx5bHB5MEZpMzdLY0YxV0MwVFFleDVLN1JSZzVNeTBTT0Nmb2xHMUtVOWoxMVVuX0U2bFgtMm9ZRnBWQVFvemtQbzRIZUpjLWZ2bDlnUTBBQmx6VWNkSC1KanEzczBldUIyRzNUZHRON0VzMFNTb2c3b1NhbjBmQUpVRGQ1TW4zamhrTnd3dmdPRG8?oc=5) |
| CNBC | Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer | [Source Link](https://news.google.com/rss/articles/CBMieEFVX3lxTE95WVdfYTlmN2laSWtJVWVjZkVQMkQ4SVFRQmJkUS0wdVprRXhqZFBPSzZpTEVKZEI5U3VBVzNBQTJJbk8xNTRCREJuV1l1RzUzZnpKQmw3QUl6UU16TWpBaUhOYmdBdk1HaVQ0OEhFdV9wSHZaSnVOV9IBfkFVX3lxTE9Sc0tWZ3AzX2FnOHdBSnJRRmlGaU9uWE1oMnVKdXgwVWEyYnVjeEYtUFZmUVVzSzZpNnZmaHNUNERwZkpicllwNl9uTkhSTU1kbkdUYjV1VTRLOHVrOGY4cThTU3FSWDZwaV9SZTYySXdfSGVvd2VCYmZheVJ0dw?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-24/amgen-says-drug-combo-cuts-risk-of-death-by-58-in-patients-with-aggressive-lung*